Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
2
self-reported 2–10 band
Founded
2021
5 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Nonprofit
self-reported
Description
The Cancer Discovery Hub (CDH) is a one-stop pan-omics diagnostic and research core laboratory housed at the National Cancer Centre Singapore. We specialise in state-of-the-art research-grade technologies and provide expert support to investigators on all cancer related projects.
Specialties
All 14 specialties
- multi-omics
- single cell sequencing
- spatial transcriptomics
- biomarkers
- clinical diagnostics
- translational research
- precision oncology
- tumor models
- organoids
- xenografts
- cell-lines
- metagenomics
- epigenomics
- next generation sequencing
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG11 Hospital Crescent; Singapore, NA 169610Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
FAQ
How many people work at Cancer Discovery Hub?
2 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Cancer Discovery Hub have offices?
One address on record, Singapore only. Primary: 11 Hospital Crescent, Singapore, NA 169610.
Has Cancer Discovery Hub raised funding?
None linked to this brand.
What does Cancer Discovery Hub list as its specialties?
14 tags on the brand's own list, among them multi-omics, single cell sequencing and spatial transcriptomics.
Which companies are listed alongside Cancer Discovery Hub?
6 profiles list Cancer Discovery Hub as a peer — 68th percentile in Biotechnology Research. It lists ten peers of its own. Megrez and 360 HealthTech Pte. Ltd. list it back.